Original research article| Volume 98, ISSUE 1, P63-68, July 2018

Download started.


Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah's Title X clinics: a retrospective review



      The objective was to assess changes in long-acting reversible contraceptive (LARC) method uptake at Utah's Title X clinics before and after introduction of a new, low-cost levonorgestrel (LNG) 52 mg IUD (Liletta®).

      Study design

      We conducted a retrospective medical record review of LARC visits occurring at seven Title-X family planning clinics in Utah before the introduction of the low-cost LNG IUD (preintroduction period: 01/01/2014–04/30/2015) and after (postintroduction period: 05/01/2015–03/31/2016). We ran segmented, interrupted time series ordinary least squares regression models using Newey–West standard errors to assess both the change in numbers of women initiating any LARC method and the average payment amount per LARC method. We evaluated both the low-cost LNG IUD and all LARC methods.


      At the outset of preintroduction period, there were 29.2 [95% confidence interval (CI): 20.1–38.4] monthly LNG IUD insertions. Immediately postintroduction, there was a significant level of increase of 14.4 LNG IUD insertions the first month (95% CI: 2.0–26.8) followed by a significant trend increase each month of 2.4 additional LNG IUD insertions (95% CI: 0.32–4.47). Postintroduction, there was a significant level of remitted-payment decrease from all sources of −$240.43 per LNG IUD (95% CI: −311.02 to 168.87) followed by a significant monthly trend decrease of −$23.01 per LNG IUD (95% CI: −32.02 to −13.98). There were minimal changes in uptake and payment of other LARC methods following the introduction of the low-cost LNG IUD.


      Following introduction of a low-cost LNG IUD at Title X clinics, LNG IUD initiation increased and average payment for the method decreased.


      Reducing the cost of LARC methods, both to clinics and to patients, is essential to expanding access. Additional efforts to develop and provide access to low-cost copper IUDs and subdermal implants as well as novel LARC methods should be continued.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kavanaugh M.L.
        • Jerman J.
        • Finer L.B.
        Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009–2012.
        Obstet Gynecol. 2015; 126: 917-927
        • Broecker J.
        • Jurich J.
        • Fuchs R.
        The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
        Contraception. 2016; 93: 266-272
        • Finer L.B.
        • Zolna M.R.
        Declines in unintended pregnancy in the United States, 2008–2011.
        N Engl J Med. 2016; 374: 843-852
      1. Obstet Gynecol. 2007; 110: 1493-1495
        • American College of O, Gynecologists
        ACOG Practice Bulletin No. 121: long-acting reversible contraception: Implants and intrauterine devices.
        Obstet Gynecol. 2011; 118: 184-196
        • Kavanaugh M.L.
        • Jerman J.
        • Ethier K.
        • Moskosky S.
        Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
        J Adolesc Health. 2013; 52: 284-292
        • Winner B.
        • Peipert J.F.
        • Zhao Q.
        • Buckel C.
        • Madden T.
        • Allsworth J.E.
        • et al.
        Effectiveness of long-acting reversible contraception.
        N Engl J Med. 2012; 366: 1998-2007
        • Mestad R.
        • Secura G.
        • Allsworth J.E.
        • Madden T.
        • Zhao Q.
        • Peipert J.F.
        Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project.
        Contraception. 2011; 84: 493-498
        • Gomez A.M.
        • Hartofelis E.C.
        • Finlayson S.
        • Clark J.B.
        Do knowledge and attitudes regarding intrauterine devices predict interest in their use?.
        Womens Health Issues. 2015; 25: 359-365
        • Harper C.C.
        • Henderson J.T.
        • Raine T.R.
        • Goodman S.
        • Darney P.D.
        • Thompson K.M.
        • et al.
        Evidence-based IUD practice: family physicians and obstetrician-gynecologists.
        Fam Med. 2012; 44: 637-645
        • Biggs M.A.
        • Rocca C.H.
        • Brindis C.D.
        • Hirsch H.
        • Grossman D.
        Did increasing use of highly effective contraception contribute to declining abortions in Iowa?.
        Contraception. 2015; 91: 167-173
        • Postlethwaite D.
        • Trussell J.
        • Zoolakis A.
        • Shabear R.
        • Petitti D.
        A comparison of contraceptive procurement pre- and post-benefit change.
        Contraception. 2007; 76: 360-365
        • Ricketts S.
        • Klingler G.
        • Schwalberg R.
        Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
        Perspect Sex Reprod Health. 2014; 46: 125-132
        • Secura G.M.
        • Allsworth J.E.
        • Madden T.
        • Mullersman J.L.
        • Peipert J.F.
        The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
        Am J Obstet Gynecol. 2010; 203: 115.e1-115.e7
        • Beeson T.
        • Wood S.
        • Bruen B.
        • Goldberg D.G.
        • Mead H.
        • Rosenbaum S.
        Accessibility of long-acting, reversible contraception (LARC) in Federally Qualified Health Centers (FQHCs).
        Contraception. 2014; 89: 91-96
        • Frost J.J.
        • Frohwirth L.
        • Zolna M.R.
        Contraceptive Needs and Services, 2014 Update.
        Guttmacher Institute, New York2016
        • AAFCPA
        Liletta IUD may offer cost savings to 340B covered entities.
        (September 12, 2016. Accessed January 16, 2018 from:)
        • Eisenberg D.L.
        • Schreiber C.A.
        • Turok D.K.
        • Teal S.B.
        • Westhoff C.L.
        • Creinin M.D.
        • et al.
        Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
        Contraception. 2015; 92: 10-16
        • Department of Health and Human Services
        340 B Drug Pricing Program.
      2. HER Salt Lake.
        Date accessed: September 8, 2017
        • Lopez-Bernal J.
        • Cummins S.
        • Gasparrini A.
        Interrupted time series regression for the evaluation of public health interventions: a tutorial.
        Int J Epidemiol. 2017; : 348-355
        • Jandoc R.
        • Burden A.M.
        • Mamdani M.
        • Levesque L.E.
        • Cadarette S.M.
        Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations.
        J Clin Epidemiol. 2015; 68: 950-956
        • Fretheim A.
        • Zang F.
        • Ross-Degnan D.
        • Oxman A.D.
        • Cheyne H.
        • Foy R.
        • et al.
        A reanalysis of cluster randomized trials showed interrupted time-series were valuable in health system evaluation.
        J Clin Epidemiol. 2015; 68: 324-333
        • Zeger S.L.
        • Irizarry R.A.
        • Peng R.D.
        On time series analysis of public health and biomedical data.
        in: Johns Hopkins University, Dept. of Biostatistics Working Papers. Working Paper 54. 2004 (from:)
        Date accessed: September 15, 2017
        • Cumby R.E.
        • Huizinga J.
        Testing the autocorrelation structure of disturbances in ordinary least squares and instrumental variables regression.
        in: Technical Working Paper No. 92. National Bureau of Economic Research, Cambridge, MA1990